Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
123,650,000
-
Total 13F shares
-
124,680,353
-
Share change
-
+1,298,325
-
Total reported value
-
$4,614,991,205
-
Put/Call ratio
-
43%
-
Price per share
-
$36.96
-
Number of holders
-
409
-
Value change
-
+$45,612,024
-
Number of buys
-
195
-
Number of sells
-
183
Institutional Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q4 2023
As of 31 Dec 2023,
HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) was held by
409 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
124,680,353 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Artisan Partners Limited Partnership, STATE STREET CORP, SNYDER CAPITAL MANAGEMENT L P, ALLIANCEBERNSTEIN L.P., MACQUARIE GROUP LTD, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, and GW&K Investment Management, LLC.
This page lists
409
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.